Phesi Introduces ClinSite™ Clinical Trial Investigator Site Selection Tool
Proven artificial intelligence (AI)-driven software now available as a self-service solution for biopharma companies Novel tool enables cutting trial participant…
Pharmaceuticals, Biotechnology and Life Sciences
Proven artificial intelligence (AI)-driven software now available as a self-service solution for biopharma companies Novel tool enables cutting trial participant…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2019 financial and operating results on Wednesday, August 7,…
KEYTRUDA is the First Anti-PD-1 Therapy to Demonstrate a Statistically Significant Improvement in pCR Rates as Neoadjuvant Therapy for TNBC…
Second-Quarter 2019 Revenues of $13.3 Billion, Reflecting 2% Operational Growth Driven by 6% Operational Growth from Pfizer Biopharmaceuticals Group Second-Quarter…
Delivers enhanced global scale and geographic reach, including leading positions in China and other emerging markets Combines Mylan’s sustainable, diverse…
Opinion Granted Based on Significant Overall Survival Benefit for KEYTRUDA in Combination with Axitinib Compared to Sunitinib in Phase 3…
DUBLIN–(BUSINESS WIRE)–The “Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. Recent approvals Although many…
DUBLIN–(BUSINESS WIRE)–The “Global Central Nervous System (CNS) Stimulant Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The rise…
The marketing application is based on phase III ATLAS and FLAIR pivotal trials in which the once-monthly, injectable treatment regimen…
Believes that biotechnology will offer solutions to some of the world’s greatest humanitarian challenges. $2 million gift to Massachusetts Ear…